Wegovy Reduces Heart Risk

This is a news story, published by Yahoo, that relates primarily to the U.S. Food and Drug Administration news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo news

For more news from Yahoo, you can click here:

more news from Yahoo

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

weight loss drug

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest weight loss news, insulin news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Wegovy

Good Morning America

•

Popular weight loss drug found to reduce risk of heart complications, study shows

Summary

Nutrition label

86% Informative

Wegovy, a drug approved by the U.S. Food and Drug Administration to treat obesity, lowers the risk of heart-related issues by up to 44% in people who are overweight or obese and without diabetes.

The study looked at over 17,000 people in 41 countries who were over the age of 45 with pre-existing heart disease.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech